- Written by GlobalData research analyst on cardiovascular devices, Priya Madhavan.

On August 6th, 2012, Sunshine Heart announced it received conditional approval from the Food and Drug Administration (FDA) for its next generation C-Pulse system driver. The new version is designed to enhance patient comfort and performance in those with moderate to severe heart failure. This new driver, or pump, consists of a single unit that is half the size of its predecessor, is quieter, and has additional software enhancements.